133 related articles for article (PubMed ID: 22614984)
21. FDG-PET Imaging in Cervical Cancer.
Gandy N; Arshad MA; Park WE; Rockall AG; Barwick TD
Semin Nucl Med; 2019 Nov; 49(6):461-470. PubMed ID: 31630730
[TBL] [Abstract][Full Text] [Related]
22. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant Chemotherapy in Locally Advanced Cervical Cancer After Treatment with Concomitant Chemoradiotherapy--Room for Improvement?
Jelavić TB; Miše BP; Strikic A; Ban M; Vrdoljak E
Anticancer Res; 2015 Jul; 35(7):4161-5. PubMed ID: 26124372
[TBL] [Abstract][Full Text] [Related]
24. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
[TBL] [Abstract][Full Text] [Related]
25. Random forests to predict tumor recurrence following cervical cancer therapy using pre- and per-treatment
Roman-Jimenez G; Acosta O; Leseur J; Devillers A; Der Sarkissian H; Guzman L; Grossiord E; Ospina JD; De Crevoisier R
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2444-2447. PubMed ID: 28324966
[TBL] [Abstract][Full Text] [Related]
26. Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy.
Chang JS; Choi SH; Lee Y; Kim KH; Park JY; Song SY; Cho A; Yun M; Lee JD; Seong J
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):126-33. PubMed ID: 25015206
[TBL] [Abstract][Full Text] [Related]
27. A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: a Korean radiation oncology group study (KROG 12-08).
Je HU; Han S; Kim YS; Nam JH; Kim HJ; Kim JW; Park W; Bae DS; Kim JH; Shin SJ; Kim J; Lee KH; Yoon MS; Kim SM; Kim JY; Yoon WS; Lee NW; Choi JH; Park SY; Kim JY
Radiother Oncol; 2014 Jun; 111(3):437-41. PubMed ID: 24909094
[TBL] [Abstract][Full Text] [Related]
28. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
[TBL] [Abstract][Full Text] [Related]
29. Prognostic models for locally advanced cervical cancer: external validation of the published models.
Lora D; Gómez de la Cámara A; Fernández SP; Enríquez de Salamanca R; Gómez JFPR
J Gynecol Oncol; 2017 Sep; 28(5):e58. PubMed ID: 28657220
[TBL] [Abstract][Full Text] [Related]
30. Clinical impact of ¹⁸F-FDG PET/CT in the pretreatment evaluation of patients with locally advanced cervical carcinoma.
Akkas BE; Demirel BB; Vural GU
Nucl Med Commun; 2012 Oct; 33(10):1081-8. PubMed ID: 22926065
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic factors for central recurrence in patients with locally advanced bulky cervical cancer.
Lee WM; Park SI; Kim BJ; Kim MH; Choi SC; Lee ED; Ryu SY
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):219-23. PubMed ID: 22326616
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
Lee TS; Kang SB; Kim YT; Park BJ; Kim YM; Lee JM; Kim SM; Kim YT; Kim JH; Kim KT
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):304-10. PubMed ID: 23642625
[TBL] [Abstract][Full Text] [Related]
33. A score combining baseline neutrophilia and primary tumor SUV
Schernberg A; Reuze S; Orlhac F; Buvat I; Dercle L; Sun R; Limkin E; Escande A; Haie-Meder C; Deutsch E; Chargari C; Robert C
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):187-195. PubMed ID: 28916879
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of posttreatment FEDG-PET imaging following combined chemoradiation therapy in locally advanced cervical cancer.
Knight S; Mancini J; Touboul C; Bolze PA; Bendifallah S; Ballester M; Collinet P; Kerbage Y; Ouldamer L; Atrous G; Lavoué V; Dion L; Dabi Y; Raimond E; Graesslin O; Huchon C; Mimouni M; Bricou A; Golfier F; Carcopino X
J Gynecol Obstet Hum Reprod; 2020 Oct; 49(8):101774. PubMed ID: 32330672
[TBL] [Abstract][Full Text] [Related]
35. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
[TBL] [Abstract][Full Text] [Related]
36. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
[TBL] [Abstract][Full Text] [Related]
37. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.
Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933
[TBL] [Abstract][Full Text] [Related]
38. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.
Valentini V; van Stiphout RG; Lammering G; Gambacorta MA; Barba MC; Bebenek M; Bonnetain F; Bosset JF; Bujko K; Cionini L; Gerard JP; Rödel C; Sainato A; Sauer R; Minsky BD; Collette L; Lambin P
J Clin Oncol; 2011 Aug; 29(23):3163-72. PubMed ID: 21747092
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
Im HJ; Yoon HJ; Lee ES; Kim TS; Kim JY; Chung JK; Kim SK; Park SY
Nucl Med Commun; 2014 Mar; 35(3):268-75. PubMed ID: 24253568
[TBL] [Abstract][Full Text] [Related]
40. FDG-PET in cervical cancer: staging, re-staging and follow-up.
Bjurberg M; Kjellén E; Ohlsson T; Ridderheim M; Brun E
Acta Obstet Gynecol Scand; 2007; 86(11):1385-91. PubMed ID: 17851810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
